SELLAS Life Sciences Group, Inc. (SLS)

4.15 +0.11 (+2.72%) USD  |  NASDAQ  |  Feb 20, 16:00
4.25 +0.10 (+2.41%) After-Hours: 20:00
More

SELLAS Life Sciences Group Current Portion of Long Term Debt (Quarterly)

Current Portion of Long Term Debt (Quarterly) Chart

View Current Portion of Long Term Debt (Quarterly) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Portion of Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Portion of Long Term Debt (Quarterly) Range, Past 5 Years

View Current Portion of Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Portion of Long Term Debt (Quarterly) Benchmarks

View Current Portion of Long Term Debt (Quarterly) Benchmarks
Start Trial
GT Biopharma, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade